Navigation Links
Rensselaer professors Dordick and Interrante named ACS Fellows
Date:10/4/2010

Troy, N.Y. Two Rensselaer Polytechnic Institute professors have been named 2010 fellows of the American Chemical Society (ACS). Director of the Center for Biotechnology and Interdisciplinary Studies (CBIS) and the Howard P. Isermann '42 Professor of Chemical and Biological Engineering Jonathan Dordick and Professor Emeritus of Chemistry Leonard Interrante were both recognized by the ACS for their "outstanding achievements in and contributions to the science, the profession, and service to the society."

"Both of these esteemed researchers and educators have had a major impact on their fields," said Rensselaer Provost Robert Palazzo. "Dr. Dordick is among the foremost biocatalysis and bioengineering experts in the world. His recent discovery of antibacterial coatings could protect thousands of people from harmful bacterial infections and his work to develop biochip technologies is transforming the way we view the modern drug discovery process.

"Dr. Interrante is both a polymer pioneer and successful entrepreneur. He has developed sophisticated new materials utilized in technologies around the world, including the Hubble Space Telescope. His pure silicon carbide-forming polymer is the only of its kind commercially available in the world, paving the way for an entirely new generation of high-temperature, high-strength ceramic composites."

The ACS honored the new fellows at the society's fall national meeting.

Dordick's research interests are in the areas of biocatalysis, bioengineering, and nanobiotechnology. He most recently developed a nanoscale coating for surgical equipment, hospital walls, and other surfaces that safely eradicates methicillin-resistant Staphylococcus aureus (MRSA). He has also discovered a biochip that could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals. The co-founder of EnzyMed Inc., a pharmaceutical discovery company, he is currently a co-founder of Solidus Biosciences, a venture-stage biotechnology company. In addition, he serves on the scientific advisory boards for several biotechnology companies and has served as chair of the division of biochemical technology for the ACS.

Dordick joined the Rensselaer faculty in 1998. He became director of CBIS in 2008. He is a fellow of both the American Institute for Medical and Biological Engineering and the American Association for the Advancement of Science (AAAS).

Dordick received his doctorate in biochemical engineering in 1986 from the Massachusetts Institute of Technology.

Interrante's research encompasses a wide range of subjects in materials chemistry. His works spans the study of both inorganic and organic polymers to the development of new, advanced materials. His ceramic and ceramic composite materials have broad applications for aerospace, industrial, and energy generation applications. His development of the pure silicon carbide forming polymer enables the processing of high-temperature, high-strength ceramic composites. The polymer helped him co-found Starfire Systems Inc., a high-tech advanced materials manufacturer that started at Rensselaer. His research is utilized in areas from aerospace to motorcycles.

Interrante joined Rensselaer in 1985. He is founding and current editor-in-chief of the ACS journal Chemistry of Materials. Before coming to Rensselaer, Interrante spent 17 years at the General Electric Research and Development Center. He is a fellow of the AAAS and was named Inventor of the Year in 2007 by Eastern New York Intellectual Property Law Association.

Interrante received his doctorate in inorganic chemistry from the University of Illinois, Urbana-Champaign in 1963.


'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-956-0701
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Rensselaer receives more than $2 million from New York State to fund stem cell research
3. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
4. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
5. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
8. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
9. Rensselaer professor uncovers mysterious workings of cholera bacteria
10. Purifying proteins: Rensselaer researchers use NMR to improve drug development
11. National Science Foundation grants Clemson professors award to develop nanoprobes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology: